Evidence map›Paper›PMID 34980884›Full record

ReviewSignal transduction and targeted therapy2022

Wnt/β-catenin signalling: function, biological mechanisms, and therapeutic opportunities.

Jiaqi Liu, Qing Xiao, Jiani Xiao, Chenxi Niu, Yuanyuan Li, Xiaojun Zhang, Zhengwei Zhou, Guang Shu, Gang Yin

Registry-linked trialOpen access · goldAbstract readReview
In one paragraph

Review in Signal transduction and targeted therapy, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07614126 (Prospective Pilot Study of L-dopa Treatment in Patients With a Neurodevelopmental Disorder Related to a Pathogenic Variant of the CTNNB1 Gene), which is not on this map. Cited by 1,499 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
1,499citing papers in PubMed, 1 pooled it
169.2field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07614126 narecruitingnot on this mapstarted 2026, after this paper: background citation

Prospective Pilot Study of L-dopa Treatment in Patients With a Neurodevelopmental Disorder Related to a Pathogenic Variant of the CTNNB1 Gene

TypeinterventionalSponsorUniversity Hospital, MontpellierRan2026 to 2027Enrolled7ConditionsCTNNB1, L-DOPAArmsL-Dopa
3 · Its place in the literature

Who cites it

1,499 citing papers in PubMed, 1 synthesis or guideline pooled it, 2,131 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. MultilevelCurrent research in structural biology · 2026
    Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Review
  18. Article
  19. Article
  20. Article

1,439 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jiaqi Liu *Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, 410013, China.
Qing Xiao *Department of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, 410013, China.
Jiani XiaoDepartment of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, 410013, China.
Chenxi NiuDepartment of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, 410013, China.
Yuanyuan LiDepartment of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, 410013, China.
Xiaojun ZhangDepartment of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, 410013, China.
Zhengwei ZhouDepartment of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, 410013, China.
Guang ShuDepartment of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, 410013, China.
Gang YinDepartment of Pathology, Xiangya Hospital, School of Basic Medical Sciences, Central South University, Changsha, 410013, China. gangyin@csu.edu.cn.ORCID http://orcid.org/0000-0003-3753-0753
Central South University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Wnt/β-catenin pathway comprises a family of proteins that play critical roles in embryonic development and adult tissue homeostasis. The deregulation of Wnt/β-catenin signalling often leads to various serious diseases, including cancer and non-cancer diseases. Although many articles have reviewed Wnt/β-catenin from various aspects, a systematic review encompassing the origin, composition, function, and clinical trials of the Wnt/β-catenin signalling pathway in tumour and diseases is lacking. In this article, we comprehensively review the Wnt/β-catenin pathway from the above five aspects in combination with the latest research. Finally, we propose challenges and opportunities for the development of small-molecular compounds targeting the Wnt signalling pathway in disease treatment.

Indexed as

Wnt Signaling PathwayAnimalsbeta CateninHumansNeoplasm ProteinsNeoplasmsWnt Proteinsbeta CateninCTNNB1 protein, humanNeoplasm ProteinsWnt Proteins

Identifiers

PMID34980884
PMCPMC8724284
OpenAlexW4205498896

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.